Range
- - -
Vol / Avg.
-/10.8K
Div / Yield
1.44/1.83%
52 Wk
60.18 - 81.15
Mkt Cap
181.7B
Payout Ratio
49.43
Open
-
P/E
26.44
EPS
5.47
Shares
2.3B
Outstanding
-
Total Float
-
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Related Companies

TickerCompanyChg %Mkt Cap
NONOFNovo Nordisk0%181.7B

Novo Nordisk Company Questions & Answers

Q

How do I buy Novo Nordisk (NONOF) stock?

A

You can purchase shares of Novo Nordisk (OTC: NONOF) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Novo Nordisk's (NONOF) main competitors?

A

There are no as such competitors for Novo Nordisk.

Q

What is the target price for Novo Nordisk?

A

There is no analysis for Novo Nordisk

Q

How much is Novo Nordisk (NONOF) stock ?

A

The stock price for Novo Nordisk (OTC: NONOF) is $79.04 last updated Mon May 17 2021 19:52:57 GMT+0000 (Coordinated Universal Time).

Q

When is the next Novo Nordisk (NONOF) dividend?

A

There are no upcoming dividends for Novo Nordisk. The last dividend paid out to investors was $0.03 on 2018-03-23.

Q

When is Novo Nordisk (OTC:NONOF) reporting earnings?

A

There are no earnings for Novo Nordisk

Q

When is the upcoming split for NONOF?

A

There is no upcoming split for Novo Nordisk.